---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-311112"
form_type: "8-K"
ticker: "AMGN"
cik: "0000318154"
company_name: "AMGEN INC"
filed_at: "2022-12-22T23:59:59+00:00"
generated_at: "2026-06-21T00:23:20.896840+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Amgen enters $4B term loan facility for Horizon acquisition, Dec 22, 2022

## Summary
- Term Loan Credit Agreement provides a $2B 18-month tranche and a $2B 3-year tranche, dated Dec 22, 2022.
- Facility replaces $4B of the $8B bridge credit facility entered Dec 12, 2022.
- Advances bear interest at SOFR + 0.875%-1.375% or base rate plus 0.000%-0.375%; ticking fee of 0.125% on undrawn commitments.
- Proceeds used to finance Horizon acquisition, repay Horizon debt, pay fees and expenses.
- Commitments terminate upon completion of acquisition or mandatory cancellation events (e.g., abandonment).

## SEC filing metadata
- accession: 0001193125-22-311112
- form_type: 8-K
- ticker: AMGN
- cik: 0000318154
- company_name: AMGEN INC
- filed_at: 2022-12-22T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318154/000119312522311112/0001193125-22-311112-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318154/000119312522311112/d429654d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-311112
- JSON: https://secwatch.observer/filing/0001193125-22-311112.json
- Plain text: https://secwatch.observer/filing/0001193125-22-311112.txt

## Key facts
- Material Agreements
  AMGEN INC entered into Term Loan Credit Agreement with Citibank, N.A., Bank of America, N.A., Goldman Sachs Bank USA, Mizuho Bank, Ltd. valued at $4,000,000,000 term loan credit facility with two tranches: $2,000,000,000 18-month and $2,000,000,0 (effective 2022-12-22).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Citibank, N.A., Bank of America, N.A., Goldman Sachs Bank USA, Mizuho Bank, Ltd.
  - Value: $4,000,000,000 term loan credit facility with two tranches: $2,000,000,000 18-month and $2,000,000,0
  - Effective: 2022-12-22
  source text: Term Loan Credit Facility On December 22, 2022 (the “ Effective Date ”), Amgen Inc. (“ Amgen ”), Citibank, N.A. (“ Citibank ”), as administrative agent, Bank of America, N.A. (“ Bank of America ”), as syndication agent, Citibank, Bank of America, Goldman Sachs Bank USA and Mizuho Bank, Ltd. as lead arrangers and book runners, and Goldman Sachs Bank USA and Mizuho Bank, Ltd. as documentation agents entered into a Term Loan Credit Agreement (the “ Term Loan Credit Agreement ”). The Term Loan Credit Agreement provides for a (1) a $2,000,000,000 18-month term loan tranche (the “ 18-Month Tranche ”) and (2) a $2,000,000,000 3-year term loan tranche (the “ 3-Year Tranche ”, and together with the 18-Month Tranche, the “ Term Loan Credit Facility ”), with the commitments under the Bridge Credit Agreement entered into by Amgen, as borrower, Citibank, as administrative agent, Bank of America, as syndication agent, and Citibank and Bank of America as lead arrangers and book runners, on December 1
  evidence_url: https://www.sec.gov/Archives/edgar/data/318154/000119312522311112/0001193125-22-311112-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.